SCHEMBL9860699

SCHEMBL9860699

COC(=O)c1c(C(=O)OC)c(-c2ccc(OC)c(OC)c2)c2cc(C)ccc2c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 1/20 0.49
MAPT P10636 5/20 0.47
ALDH1A1 P00352 4/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
CYP3A4 P08684 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
MAPK1 P28482 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 1/20 0.44
ERN1 O75460 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAOB P27338 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9860680 0.89 SLC10A2 (0.56) SLC10A2MAPTALDH1A1MAPK1HPGD
SCHEMBL9861231 0.86 SLC10A2 (0.52) SLC10A2MAPTALDH1A1KMT2AKDM4E
SCHEMBL9860695 0.84 SLC10A2 (0.53) SLC10A2MAPTALDH1A1MAPK1HPGD
SCHEMBL8684117 0.81 NPC1 (0.54) SLC10A2MAPTALDH1A1KMT2AKDM4E
SCHEMBL9860466 0.78 SLC10A2 (0.68) SLC10A2MAPTALDH1A1MAPK1HPGD
SCHEMBL9860487 0.78 SLC10A2 (0.54) SLC10A2MAPTALDH1A1KDM4EMAPK1
SCHEMBL8688163 0.77 SLC10A2 (0.76) SLC10A2MAPTALDH1A1KMT2AMEN1
SCHEMBL29740792 0.77 SLC10A2 (0.76) SLC10A2MAPTALDH1A1KMT2AMEN1
SCHEMBL8684556 0.77 ALDH1A1 (0.49) SLC10A2MAPTALDH1A1KDM4EMAPK1
SCHEMBL9861222 0.77 ERN1 (0.49) SLC10A2HPGDERN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5070103-A ANTILIPEMIC AGENTS, ARTERIOSCLEROSIS TANABE SEIYAKU CO., LTD. (JP) 1991-12-03 US claimed
US-5070103-A ANTILIPEMIC AGENTS, ARTERIOSCLEROSIS TANABE SEIYAKU CO., LTD. (JP) 1991-12-03 US disclosed
EP-0188248-B1 NAPHTHALENE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME TANABE SEIYAKU CO., LTD. (JP) 1990-07-11 EP disclosed
US-4897418-A ANTILIPEMIC AGENTS TANABE SEIYAKU CO., LTD. (JP) 1990-01-30 US disclosed
US-4771072-A HYPOLIPIDEMIC ACTIVITY TANABE SEIYAKU CO., LTD. (JP) 1988-09-13 US disclosed
EP-0188248-A2 Naphthalene derivatives, process for the preparation thereof and pharmaceutical composition containing same TANABE SEIYAKU CO., LTD. (JP) 1986-07-23 EP disclosed